查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1427183

全球電生理設備市場規模、佔有率、成長分析、按應用、按適應症、按最終用途 - 2023-2030 年產業預測

Global Electrophysiology Devices Market Size, Share, Growth Analysis, By Application, By Indication(Atrial Fibrillation, Supraventricular Tachycardia), By End-Use - Industry Forecast 2023-2030
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球電生理設備市場規模為61億美元，在預測期（2024-2031年）從2023年的67.8億美元成長到2031年的158.1億美元，預計複合年成長率為11.16 %。

除了擴大使用電生理學(EP) 測試來預防和治療心房顫動等心臟病之外，對心律管理設備的需求也不斷成長，尤其是在醫院外進行持續監測。這就是推動這一趨勢的原因行業的成長。據美國疾病管制與預防中心稱，久坐的生活方式、吸煙和過量飲酒等因素導致千禧一代心臟衰竭、心臟心臟麻痹和心房顫動的發病率增加。據美國疾病控制和預防中心稱，估計有1,210 萬美國患有心臟衰竭、心臟衰竭和心房顫動。預計到 2030 年將出現心房顫動。此外，根據歐洲心臟學會的說法，心房顫動在歐洲裔美國人中比非裔美國人更常見，並且是西方國家心臟麻痹的主要原因。這就是導致這種疾病的原因，其發生率為1%。每年1,000人。由於心臟病患病率不斷上升，電生理設備對於心律不整的檢測和治療至關重要，正在推動市場擴張。這些設備促進了行動心臟監測和動態心電圖（ECG）追蹤，而植入式心臟設備的遠端監測、雲端資料儲存和無線傳輸等進步進一步推動了市場成長。這些技術進步不僅使醫療保健提供者能夠獲得寶貴的患者資訊，例如消融治療的 3D 照片和影片，而且符合患者對微創治療的偏好。冷凍消融、雷射治療、超音波消融和增強測繪技術等新興技術有望為該領域帶來更多好處。值得注意的是，Medtronic力於2022年2月FDA核准Freezor ， Freezor強調了進步和創新。

自上而下和自下而上的方法已用於估計和檢驗全球電生理設備市場的規模，並估計其他各個相關子市場的規模。用於估計市場規模的調查方法包括以下詳細資訊：用於確定市場主要企業的二次研究，用於確定每個地區的市場佔有率的主要和二次研究。整個過程包括研究主要企業的年度和財務報告以及廣泛的採訪，以獲得執行長、副總裁、董事和行銷負責人等行業領導者的重要見解。所有股份比率和細分均使用二手資訊確定並使用主要資訊檢驗。本研究涵蓋的所有可能影響市場的參數都經過詳細考慮，並透過初步研究檢驗並進行分析，以獲得最終的定量和定性資料。

全球電生理設備市場按細分市場分析

全球電生理設備市場根據應用、適應症、最終用途和地區進行細分。依用途分為治療設備和診斷設備。根據適應症，市場分為心房顫動（AF）、室上性心搏過速、房室結折返性心動過速（AVNRT）、沃爾夫-巴金森-懷特氏症候群（WPW）、心搏過緩等。根據最終用途，市場分為醫院、門診手術中心等。按地區分類，全球電生理設備市場分為北美、歐洲、亞太地區、南美洲和中東和非洲。

電生理設備的全球市場促進因素

心房顫動和心室心搏過速等心律不整的發生率不斷增加，大大推動了對電生理設備的需求。這些疾病需要準確的診斷和治療，而電生理設備非常適合促進這一點。

全球電生理設備市場的限制因素

然而，電生理設備的負擔能力是一個挑戰，可能會阻礙其廣泛普及，特別是在醫療保健預算有限的地區或具有嚴格報銷政策的醫療保健框架中。電生理測試設備的高成本可能會阻礙市場成長。

全球電生理設備市場趨勢

在電生理學領域，微創技術正變得越來越流行。技術和導管設計的進步使得基於導管的手術更容易更精確地診斷和治療心律不整，最大限度地減少患者的不適，縮短恢復時間，並且現在可以減少併發症的可能性。

目錄

  • 執行摘要
  • 調查方法
  • 母市場分析
  • 主要市場考察
    • 技術分析
    • 價格分析
    • 供應鏈分析
    • 價值鏈分析
    • 市場生態系統
    • 智慧財產權分析
    • 貿易分析
    • Start-Ups分析
    • 原料分析
    • 創新矩陣
    • 研發線產品分析
    • 總體經濟指標
    • 主要投資分析
    • 關鍵成功因素
    • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
    • 監管形勢
    • 波特的分析
    • 對未來中斷的特殊考慮
  • 全球電生理設備市場：依應用分類
    • 市場概況
    • 治療設備
    • 診斷設備
  • 全球電生理設備市場：依適應症分類
    • 市場概況
    • 心房顫動（AF）
    • 心室上性心搏過速
    • 房室結折返性心搏過速(AVNRT)
    • 沃爾夫-巴金森-懷特氏症候群(WPW)
    • 心搏過緩
    • 其他
  • 全球電生理設備市場：依最終用途分類
    • 市場概況
    • 醫院
    • 門診手術中心
    • 其他
  • 全球電生理設備市場規模：依地區分類
    • 市場概況
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
      • 德國
      • 西班牙
      • 法國
      • 英國
      • 其他歐洲國家地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 拉丁美洲
      • 巴西
      • 其他拉丁美洲地區
    • 中東和非洲 (MEA)
      • 海灣合作理事會國家
      • 南非
      • 其他中東/非洲地區
  • 競爭形勢
    • 前5名企業對比
    • 主要企業市場定位（2021年）
    • 主要市場參與者所採取的策略
    • 關鍵成功策略
    • 近期市集活動
    • 主要企業市場佔有率（2021年）
  • 主要企業簡介
    • Abbott Laboratories
    • Medtronic plc
    • Boston Scientific Corporation
    • Biosense Webster（a Johnson & Johnson company）
    • St. Jude Medical（part of Abbott Laboratories）
    • Siemens Healthineers
    • Koninklijke Philips NV
    • GE Healthcare
    • MicroPort Scientific Corporation
    • Biotronik SE & Co. KG
    • CardioFocus Inc.
    • LivaNova PLC
    • Penumbra, Inc.
    • Stereotaxis, Inc.
    • nContact, Inc.（part of AtriCure, Inc.）
    • Advanced Cardiac Therapeutics, Inc.
    • CathRx Ltd.
    • Osypka Medical GmbH
    • Auris Health, Inc.（part of Johnson & Johnson）
    • AngioDynamics, Inc.
簡介目錄
Product Code: SQMIG35A2420

Global Electrophysiology Devices Market size was valued at USD 6.10 billion in 2022 and is poised to grow from USD 6.78 billion in 2023 to USD 15.81 billion by 2031, growing at a CAGR of 11.16% during the forecast period (2024-2031).

The increasing utilization of electrophysiology (EP) tests for both preventing and treating heart diseases like atrial fibrillation, alongside a rising demand for cardiac rhythm management equipment for continuous monitoring, particularly in out-of-hospital settings, is propelling industry growth. Factors such as sedentary lifestyles, smoking, excessive alcohol consumption, among others, contribute to the rising incidence of heart failure, sudden cardiac arrest, and atrial fibrillation among millennials, with an estimated 12.1 million Americans projected to have AF by 2030, according to the Centers for Disease Control and Prevention. Moreover, atrial fibrillation affects Europeans more than African Americans, and it stands as a leading cause of sudden cardiac arrest in Western countries, affecting around one in every 1,000 individuals annually, as stated by the European Society of Cardiology. Electrophysiology devices, integral for detecting and managing heart arrhythmias, are driving market expansion due to the escalating prevalence of heart disease. These devices facilitate mobile cardiac monitoring and ambulatory electrocardiogram (ECG) tracking, while advancements like remote monitoring of implanted cardiac devices, data storage in the cloud, and wireless transmission further fuel market growth. This technological progress not only grants healthcare providers access to valuable patient information, including 3D photos and videos from ablation treatments but also aligns with patients' preference for minimally invasive procedures. Emerging techniques such as cryoablation, laser therapy, ultrasonic ablation, and enhanced mapping technologies promise additional benefits to the sector. Notably, Medtronic's FDA approval of the Freezor & Freezor Xtra Cardiac Cryoablation Focal Catheters in February 2022 for managing Atrioventricular Nodal Reentrant Tachycardia (AVNRT) in pediatric patients underscores the continued advancement and innovation in cardiac care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electrophysiology Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electrophysiology Devices Market Segmental Analysis

The global electrophysiology devices market is segmented on the basis of application, indication, end-use, and region. Based on application, the market is segmented into treatment devices, and diagnostic devices. Based on indication, the market is segmented into Atrial Fibrillation (AF), Supraventricular Tachycardia, Atrioventricular Nodal Re-entry Tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), Bradycardia, and other. Based on end-use the market is segmented into hospitals, ambulatory surgical centers, and others. Based on region the global Electrophysiology Devices Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Electrophysiology Devices Market

The increasing incidence of cardiac arrhythmias like atrial fibrillation and ventricular tachycardia significantly fuels the demand for electrophysiology devices. These conditions necessitate precise diagnosis and treatment, tasks that electrophysiology devices excel at facilitating.

Restraints in the Global Electrophysiology Devices Market

However, the affordability of electrophysiology devices presents a challenge, potentially hindering their widespread use, especially in areas with constrained healthcare budgets or within healthcare frameworks governed by stringent reimbursement policies. The substantial expenses associated with these devices can impede market growth.

Market Trends of the Global Electrophysiology Devices Market

Minimally invasive techniques are increasingly popular in the realm of electrophysiology. Progress in technology and catheter design has facilitated the creation of procedures that utilize catheters to diagnose and treat cardiac arrhythmias with enhanced precision, while also minimizing patient discomfort, shortening recovery periods, and reducing the likelihood of complications.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
    • Regulatory Landscape
    • Porters Analysis
      • Competitive rivalry
      • Threat of Substitute Products
      • Bargaining Power of Buyers
      • Threat of New Entrants
      • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
      • Political Impact
      • Economic Impact
      • Social Impact
      • Technical Impact
      • Environmental Impact
      • Legal Impact
  • Global Electrophysiology Devices Market by Application
    • Market Overview
    • Treatment Devices
    • and Diagnostic Devices
  • Global Electrophysiology Devices Market by Indication
    • Market Overview
    • Atrial Fibrillation (AF)
    • Supraventricular Tachycardia
    • Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
    • Wolff-Parkinson-White Syndrome (WPW)
    • Bradycardia
    • and Other
  • Global Electrophysiology Devices Market by End-Use
    • Market Overview
    • Hospitals
    • Ambulatory Surgical Centers
    • and Others
  • Global Electrophysiology Devices Market Size by Region
    • Market Overview
    • North America
      • USA
      • Canada
    • Europe
      • Germany
      • Spain
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC Countries
      • South Africa
      • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
      • By Development
      • By Company
      • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Abbott Laboratories
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Medtronic plc
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Boston Scientific Corporation
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Biosense Webster (a Johnson & Johnson company)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • St. Jude Medical (part of Abbott Laboratories)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Siemens Healthineers
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Koninklijke Philips N.V.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • GE Healthcare
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • MicroPort Scientific Corporation
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Biotronik SE & Co. KG
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • CardioFocus Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • LivaNova PLC
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Penumbra, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Stereotaxis, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • nContact, Inc. (part of AtriCure, Inc.)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Advanced Cardiac Therapeutics, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • CathRx Ltd.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Osypka Medical GmbH
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Auris Health, Inc. (part of Johnson & Johnson)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • AngioDynamics, Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments